Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Single oral doses of palosuran are reported safe in healthy volunteers

Oct. 5, 2004

Phase IIa study of BXL-628 for BPH meets primary endpoint

Sep. 29, 2004

New approvals for tamsulosin formulations

Sep. 27, 2004

GSK researchers describe new SGK-1 inhibitors and their use

Sep. 23, 2004

Bayer patent covers new PGI2 antagonists for urological disorders and other uses

Sep. 17, 2004

Yentreve launched in Europe

Sep. 15, 2004

Ranbaxy researchers present novel muscarinic antagonists

Sep. 15, 2004

Positive one-year data for NX-1207 in BPH

Sep. 13, 2004

Proscar approved for new indication in Canada

Sep. 7, 2004

Botulinum toxin A shows promise in the treatment of detrusor overactivity

Sep. 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...